Detalles de la búsqueda
1.
Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post-hoc Analysis of KALM-1 and KALM-2.
Am J Nephrol;
2024 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253036
2.
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
BMC Nephrol;
24(1): 18, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658531
3.
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
J Am Soc Nephrol;
33(4): 850-866, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35361724
4.
Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
BMC Nephrol;
23(1): 59, 2022 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135481
5.
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
Am J Kidney Dis;
77(2): 255-263, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771648
6.
Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm.
J Ren Nutr;
31(1): 21-34, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32386937
7.
The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Am J Kidney Dis;
76(6): 765-774, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682697
8.
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.
Nephrol Dial Transplant;
35(6): 946-954, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32259248
9.
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.
Nephrol Dial Transplant;
35(10): 1769-1778, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30859218
10.
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trialâ©.
Clin Nephrol;
94(1): 26-35, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449678
11.
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
J Am Soc Nephrol;
30(9): 1723-1733, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31201218
12.
The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.
Kidney Int;
96(2): 470-479, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31262489
13.
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Nephrol Dial Transplant;
34(7): 1163-1170, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846719
14.
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
J Am Soc Nephrol;
29(10): 2458-2470, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30228150
15.
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
Ann Intern Med;
167(6): 375-383, 2017 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-28869987
16.
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide.
Nephrol Dial Transplant;
32(8): 1330-1338, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27342579
17.
One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis.
Nephrol Dial Transplant;
32(11): 1918-1926, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28339993
18.
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia.
J Am Soc Nephrol;
27(4): 1234-44, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26494831
19.
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients.
Am J Nephrol;
44(2): 104-12, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27434393
20.
New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.
Curr Hypertens Rep;
18(7): 55, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27230070